From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...

Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC) have developed a series of light-activatable drug candidates that could serve ...

University of Virginia School of Medicine researchers have revealed how the popular, low-carb ketogenic diet protects against epilepsy seizures and possibly neurodegenerative diseases such as ...

Avion Pharmaceuticals, an Alora Pharmaceuticals subsidiary company focused on advancing treatment for Parkinson's disease, is proud to announce the findings from a recently published study examining ...

POO pills’ could dramatically improve cancer treatment, boosting its effectiveness while reducing toxic side effects, scientists say. Also known as faecal microbiota transplants ...

Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC) ...

Phase 1b clinical site start-up and regulatory activities in Australia underway to support the global registrational program -HUNTSVILLE, AL, ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...

More than a decade ago, GLP-1 drugs began being marketed for weight loss. Sexenda was approved in the U.S. in 2014, and ...

By Vijay Kumar Malesu Digestive symptoms often appear years before tremor in Parkinson’s disease, and growing evidence ...

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Phase 1b clinical site start-up and regulatory activities in Australia underway to support the global registrational program - HUNTSVILLE, AL, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics ...